Funder
National Key R&D Program of China
National Natural Science Foundation of China
Hangzhou Science and Technology Project
the Independent Task of State Key Laboratory for Diagnosis and Treatment of Infectious Diseases
Fundamental Research Funds for the Central Universities
CAMS Innovation Fund for Medical Sciences
Publisher
Springer Science and Business Media LLC
Reference261 articles.
1. Williams, R. (2006). Global challenges in liver disease. Hepatology, 44(3), 521–526.
2. Xiao, J., Wang, F., Wong, N. K., He, J., Zhang, R., Sun, R., Xu, Y., Liu, Y., Li, W., Koike, K., et al. (2019). Global liver disease burdens and research trends: Analysis from a Chinese perspective. Journal of Hepatology, 71(1), 212–221.
3. Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 68(6), 394–424.
4. Berasain, C., Arechederra, M., Argemi, J., Fernandez-Barrena, M. G., & Avila, M. A. (2023). Loss of liver function in chronic liver disease: An identity crisis. Journal of Hepatology, 78(2), 401–414.
5. Rumgay, H., Ferlay, J., de Martel, C., Georges, D., Ibrahim, A. S., Zheng, R., Wei, W., Lemmens, V., & Soerjomataram, I. (2022). Global, regional and national burden of primary liver cancer by subtype. European Journal of Cancer, 161, 108–118.